Continue Reading
Full article on CNBC
Novo Nordisk and Eli Lilly fall after Hims & Hers announce $49 copy of Wegovy pill
Market Intelligence Analysis
AI-Powered
Why This Matters
Novo Nordisk and Eli Lilly's stocks have declined due to Hims & Hers' announcement of a $49 generic version of Wegovy, a significant price drop from the $149 branded pill.
Market Impact
Market impact analysis based on bearish sentiment with 90% confidence.
Sentiment
Bearish
AI Confidence
90%
Time Horizon
Short Term
Article Context
Note: This is a brief excerpt for context. Click below to read the full article on the original source.
Novo Nordisk and Eli Lilly fell after Hims & Hers said it will offer a copy of the Wegovy pill for $49, far less than the $149 Novo sells the branded pill for.
Original article published by
CNBC
on February 5, 2026.
Analysis and insights provided by AnalystMarkets AI.
Analysis and insights provided by AnalystMarkets AI.